NNT (Nicotinamide Nucleotide Transhydrogenase)
Mitochondrial NADPH production and redox homeostasis gene
Gene Information Card
| Symbol | NNT |
|---|---|
| Full Name | Nicotinamide Nucleotide Transhydrogenase |
| Gene Type | Protein coding |
| Chromosomal Location | 5p12 |
| NCBI Gene ID | 23530 ncbi.nlm.nih.gov/gene/23530 |
| Ensembl ID | ENSG00000112984 |
| UniProt ID | Q13423 |
| OMIM ID | 607878 |
| HGNC ID | 7863 |
| Aliases | NNTM, NAD(P) transhydrogenase, mitochondrial |
Description
The NNT gene encodes nicotinamide nucleotide transhydrogenase, a mitochondrial inner membrane protein that catalyzes the transfer of a hydride ion from NADH to NADP+ to produce NADPH. This reaction is coupled to the proton gradient across the mitochondrial membrane. NADPH is essential for antioxidant defense (e.g., regeneration of glutathione and thioredoxin), steroidogenesis, and other biosynthetic pathways. Mutations in NNT cause familial glucocorticoid deficiency type 4 and have been associated with primary hyperoxaluria and other metabolic disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Familial glucocorticoid deficiency type 4 | Loss-of-function mutations impair NADPH production in adrenal cortex, reducing cortisol synthesis | OMIM #614736; ClinVar |
| Primary hyperoxaluria | Defective NADPH leads to increased oxidative stress and glyoxylate metabolism disruption | ClinVar; PubMed studies |
| Adrenal insufficiency (general) | Impaired steroidogenesis due to insufficient NADPH for cytochrome P450 enzymes | OMIM; NCBI GeneReviews |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adrenal gland | 28.5 | High |
| Liver | 15.2 | Medium |
| Kidney | 12.8 | Medium |
| Heart | 10.1 | Medium |
| Brain | 6.3 | Low |
| Skeletal muscle | 4.7 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 (liver) | 18.4 | High expression |
| HEK293 (embryonic kidney) | 14.2 | Medium expression |
| K562 (leukemia) | 8.9 | Low expression |
| A549 (lung) | 7.3 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.469C>T (p.Arg157*) | Nonsense | Rare | Loss of function; truncation |
| c.1319G>A (p.Arg440His) | Missense | Rare | Impaired catalytic activity |
| c.1850_1851del (p.Leu617fs) | Frameshift | Rare | Loss of function |
| c.2623C>T (p.Arg875Cys) | Missense | Rare | Reduced NADPH production |
Mutation functional classification
Loss of Function (LOF)
Most reported NNT mutations are loss-of-function, leading to reduced NADPH levels and impaired antioxidant capacity and steroidogenesis.
Gain of Function (GOF)
No gain-of-function mutations have been described for NNT.
Dominant Negative (DN)
No dominant-negative mechanisms have been reported; inheritance is autosomal recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• NADPH regeneration (mitochondrial)
• Glutathione metabolism
• Steroid hormone biosynthesis
• Pentose phosphate pathway (indirect)
Protein Summary
Nicotinamide nucleotide transhydrogenase (NNT) is a 1086-amino-acid mitochondrial inner membrane protein. It uses the proton motive force to catalyze the reversible transfer of a hydride from NADH to NADP+, generating NADPH. NADPH is critical for mitochondrial antioxidant systems (e.g., glutathione reductase, thioredoxin reductase) and for cytochrome P450-dependent steroidogenesis. NNT deficiency leads to increased oxidative stress and impaired cortisol synthesis, causing familial glucocorticoid deficiency.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TNNT2 Knockout HEK293 Cell Line | EDJ-KQ939 | Human | 7139 | Details Get a Quote |
| NNT Knockout HEK293 Cell Line | EDJ-KQ8047 | Human | 23530 | Details Get a Quote |
| TNNT1 Knockout HEK293 Cell Line | EDJ-KQ15875 | Human | 7138 | Details Get a Quote |
| TNNT3 Knockout HEK293 Cell Line | EDJ-KQ15876 | Human | 7140 | Details Get a Quote |
| TNNT2 Knockout HeLa Cell Line | EDJ-KQ19919 | Human | 7139 | Details Get a Quote |
| TNNT1 Knockout HCT 116 Cell Line | EDJ-KQ49094 | Human | 7138 | Details Get a Quote |
| TNNT1 Knockout HeLa Cell Line | EDJ-KQ49095 | Human | 7138 | Details Get a Quote |
| NNT Knockout A-549 Cell Line | EDJ-KQ33856 | Human | 23530 | Details Get a Quote |
| NNT Knockout HeLa Cell Line | EDJ-KQ33857 | Human | 23530 | Details Get a Quote |
| TNNT1 Knockout A-549 Cell Line | EDJ-KQ46871 | Human | 7138 | Details Get a Quote |
| TNNT1 Knockout Huh-7.5.1 Cell Line | EDJ-KZ55 | Human | 7138 | Details Get a Quote |
| TNNT3 Knockout HeLa Cell Line | EDJ-KQ54681 | Human | 7140 | Details Get a Quote |
| TNNT2 Knockout A-549 Cell Line | EDJ-KQ63163 | Human | 7139 | Details Get a Quote |
| TNNT3 Knockout A-549 Cell Line | EDJ-KQ63164 | Human | 7140 | Details Get a Quote |
| TNNT2 Knockout HCT 116 Cell Line | EDJ-KQ71637 | Human | 7139 | Details Get a Quote |
Displaying Records 1 To 15 Of 17 Records